Cleared Traditional

K914815 - IL TEST(TM) BENZODIAZEPINE

K914815 is an FDA 510(k) clearance for IL TEST(TM) BENZODIAZEPINE, manufactured by Instrumentation Laboratory CO. The device is a Class 2 Chemistry device with product code JXM cleared through the Traditional 510(k) pathway after a 94-day FDA review.

K914815 · Instrumentation Laboratory CO · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1992
Decision
94d
Days
Class 2
Risk

K914815 is an FDA 510(k) clearance for the IL TEST(TM) BENZODIAZEPINE. Classified as Enzyme Immunoassay, Benzodiazepine (product code JXM), Class II - Special Controls.

Submitted by Instrumentation Laboratory CO (Lexington, US). The FDA issued a Cleared decision on January 27, 1992 after a review of 94 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.3170 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Instrumentation Laboratory CO devices

FDA 510(k) Submission Details - K914815

510(k) Number K914815 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 25, 1991
Decision Date January 27, 1992
Days to Decision 94 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
6d slower than avg
Panel avg: 88d · This submission: 94d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JXM Device Classification - Class 2, Special Controls

Product Code JXM Enzyme Immunoassay, Benzodiazepine
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.3170
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - JXM Enzyme Immunoassay, Benzodiazepine

All 80
Devices cleared under the same product code (JXM) and FDA review panel - the closest regulatory comparables to K914815.
EMIT(R) D.A.U. BENZODIAZEPINE ASSAY
K931536 · Syva Co. · May 1993
EMIT(R) II BENZODIAZEPINE ASSAY
K926067 · Syva Co. · Jan 1993
EMIT D.A.U BENZODIAZEPINE ASSAY
K915501 · Syva Co. · Feb 1992
ABUSCREEN(R) ONLINE(TM) FOR BENZODIAZEPINES
K914509 · Roche Diagnostic Systems, Inc. · Nov 1991
ABUSCREEN ONTRAK FOR BENZODIAZEPINE
K910590 · Roche Diagnostic Systems, Inc. · Apr 1991
EMIT II BENZODIAZEPINE ASSAY
K910376 · Syva Co. · Feb 1991